| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRAY | Common Stock | Sale | -$1.85M | -34.1K | -48.29% | $54.30 | 36.5K | 17 Nov 2021 | Direct | F1 |
| transaction | XRAY | Common Stock | Sale | -$581K | -10.7K | -29.45% | $54.08 | 25.7K | 17 Nov 2021 | Direct | F2 |
| transaction | XRAY | Common Stock | Options Exercise | $841K | +17.7K | +68.95% | $47.41 | 43.5K | 17 Nov 2021 | Direct | |
| transaction | XRAY | Common Stock | Sale | -$960K | -17.7K | -40.81% | $54.11 | 25.7K | 17 Nov 2021 | Direct | F3 |
| transaction | XRAY | Common Stock | Options Exercise | $373K | +9.3K | +36.13% | $40.12 | 35K | 17 Nov 2021 | Direct | |
| transaction | XRAY | Common Stock | Sale | -$503K | -9.3K | -26.54% | $54.09 | 25.7K | 17 Nov 2021 | Direct | F4 |
| transaction | XRAY | Common Stock | Options Exercise | $450K | +9.13K | +35.49% | $49.29 | 34.9K | 17 Nov 2021 | Direct | |
| transaction | XRAY | Common Stock | Sale | -$494K | -9.13K | -26.19% | $54.12 | 25.7K | 17 Nov 2021 | Direct | F5 |
| transaction | XRAY | Common Stock | Options Exercise | $260K | +5.43K | +21.11% | $47.84 | 31.2K | 17 Nov 2021 | Direct | |
| transaction | XRAY | Common Stock | Sale | -$294K | -5.43K | -17.43% | $54.09 | 25.7K | 17 Nov 2021 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRAY | Stock Option (Right to Buy) | Options Exercise | $0 | -17.7K | -100% | $0.00* | 0 | 17 Nov 2021 | Common Stock | 17.7K | $47.41 | Direct | F7 |
| transaction | XRAY | Stock Option (Right to Buy) | Options Exercise | $0 | -9.3K | -100% | $0.00* | 0 | 17 Nov 2021 | Common Stock | 9.3K | $40.12 | Direct | F8 |
| transaction | XRAY | Stock Option (Right to Buy) | Options Exercise | $0 | -9.13K | -66.67% | $0.00 | 4.57K | 17 Nov 2021 | Common Stock | 9.13K | $49.29 | Direct | F9 |
| transaction | XRAY | Stock Option (Right to Buy) | Options Exercise | $0 | -5.43K | -33.34% | $0.00 | 10.9K | 17 Nov 2021 | Common Stock | 5.43K | $47.84 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F7 | This option is fully vested and exercisable. |
| F8 | This option is fully vested and exercisable. |
| F9 | Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022. |
| F10 | Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023. |